First-in-human, phase I/IIa clinical study of the peptidase potentiated alkylator melflufen administered every three weeks to patients with advanced solid tumor malignancies
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Peter Nygren Hans Hagberg |
| Publication date | November 10, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |